NCT04690205View on ClinicalTrials.gov

Hospital at Home at EOL in Heme Malignancies

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 26, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2025

Conditions
Hematologic Malignancy
Interventions
OTHER

End of Life (EOL) Care at at Home

Remote monitoring and home-based care designed for patients with advanced hematologic malignancies

Trial Locations (1)

02114

Massachusetts General Hospital Cancer Center, Boston

Sponsors

Collaborators (1)

Medically Home
All Listed Sponsors
collaborator

Medically Home

UNKNOWN

lead

Massachusetts General Hospital

OTHER